Quick Answer
Kiwi Constipation Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Significant improvements in overall IBS symptom severity were observed ( P P P P P P Conclusion While further research is needed, this is a promising first report that enzymatic digestion may have the potential to decrease the burden of disorders of the gut-brain interaction, including IBS.
Key Takeaways
- 01Significant improvements in overall IBS symptom severity were observed ( P P P P P P Conclusion While further research is needed, this is a promising first report that enzymatic digestion may have the potential to decrease the burden of disorders of the gut-brain interaction, including IBS. [Kaye AJ (2026)]
- 02Background and aims Irritable bowel syndrome (IBS) is a highly prevalent and morbid condition that causes tremendous symptom burden, impacts quality of life, and generates substantial healthcare costs. [Kaye AJ (2026)]
- 03Current therapies are challenging to utilize and do not provide relief to many patients, creating a clear need for new innovation. [Kaye AJ (2026)]
- 04Among dietary interventions, the most consistent clinical evidence supports the use of soluble fiber (e.g., psyllium), kiwifruit or prunes, and magnesium- or sulfate-rich mineral waters to improve stool frequency and consistency. [Ribichini E (2026)]
The current Migaku evidence database contains 2 reusable source documents for Kiwi Constipation Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- Significant improvements in overall IBS symptom severity were observed ( P P P P P P Conclusion While further research is needed, this is a promising first report that enzymatic digestion may have the potential to decrease the burden of disorders of the gut-brain interaction, including IBS. [Kaye AJ (2026); evidence level 3]
- Background and aims Irritable bowel syndrome (IBS) is a highly prevalent and morbid condition that causes tremendous symptom burden, impacts quality of life, and generates substantial healthcare costs. [Kaye AJ (2026); evidence level 3]
- Current therapies are challenging to utilize and do not provide relief to many patients, creating a clear need for new innovation. [Kaye AJ (2026); evidence level 3]
- Among dietary interventions, the most consistent clinical evidence supports the use of soluble fiber (e.g., psyllium), kiwifruit or prunes, and magnesium- or sulfate-rich mineral waters to improve stool frequency and consistency. [Ribichini E (2026); evidence level 4]
- Chronic constipation (CC) is a common disorder of gut-brain interaction that markedly impairs quality of life and remains challenging to manage. [Ribichini E (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources